Orange Book product · Generic (ANDA)
MUPIROCIN
MUPIROCIN
At a glance
May 13, 2025
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 13, 2025
1 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
MUPIROCIN
Strength
2%
Dosage form
OINTMENT
Route
TOPICAL
TE code
AB
Application
ANDA 217943
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of MUPIROCIN
- 2002CENTANYBrand (NDA)
NDA 050788 · PADAGIS US
- 1987BACTROBANBrand (NDA)
NDA 050591 · GLAXOSMITHKLINE
- 2011MUPIROCINGeneric (ANDA)
ANDA 090480 · GLENMARK PHARMS
- 2005MUPIROCINGeneric (ANDA)
ANDA 065192 · FOUGERA PHARMS
- 2005MUPIROCINGeneric (ANDA)
ANDA 065170 · SUN PHARMA CANADA
- 2003MUPIROCINGeneric (ANDA)
ANDA 065123 · PADAGIS ISRAEL
- 2003MUPIROCINGeneric (ANDA)
ANDA 065085 · TEVA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
